Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Taisho Licenses in Antiobesity Agents from Arena
February 12, 2001
- WORLD NEWS IN BRIEF
February 12, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
February 5, 2001
- Kirin Obtains Rights to Cerus's Allogeneic Cellular Immune Therapy Technology
February 5, 2001
- NHI Prices of 12 New Ingredients Including Tamiflu, Relenza Approved
February 5, 2001
- Kissei, Teikoku Hormone to Codevelop Threatened Premature Delivery Treatment
February 5, 2001
- Peak Sales of 5 New Drugs Expected to Exceed \10 Bil.: Chuikyo
February 5, 2001
- Proposed Human Genome Research GL Explained by Kyoto Univ. Professor
February 5, 2001
- Chuikyo Members Point Out Problems with NHI Price Setting Rules
February 5, 2001
- Foundation for Biomedical Research and Innovation Ties Up with Quintiles
February 5, 2001
- Korosho Holds 1st Explanatory Meeting for Prefectural Governmental Officials -1-
February 5, 2001
- Issues on PMS Discussed at JSWP Forum
February 5, 2001
- Total Abolishment of Financial Contribution to Elderly Healthcare Unrealistic: Korosho Senior Vice Minister
February 5, 2001
- JUSCO Ties Up with Welpark
February 5, 2001
- NDA Review Process Needs Further Improvement: New PMSB Director General
February 5, 2001
- Tsuruha to Enter Central Tokyo Market
February 5, 2001
- Council on Drugs and Food Sanitation Holds First Meeting
February 5, 2001
- Kobayashi Pharm Acquires Whitehall Japan Corp.
February 5, 2001
- JMA, Kemporen Leaders Agree on Need to Exchange Opinions in April
February 5, 2001
- OTC NEWS IN BRIES
February 5, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…